Verastem reported $109.5M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Alaunos Therapeutics USD 46M 39M Jun/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Curis USD 3M 10M Jun/2026
Cytokinetics USD 8.19B 420M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Incyte USD 18.73B 660M Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 5.31B 572M Mar/2026
Verastem USD 110M 486M Jun/2026